FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,739,000 | +100.1% | 285,058 | -9.6% | 0.00% | +100.0% |
| Q4 2020 | $5,367,000 | +302.3% | 315,475 | +11.2% | 0.00% | +100.0% |
| Q3 2020 | $1,334,000 | +2.3% | 283,759 | +32.8% | 0.00% | 0.0% |
| Q2 2020 | $1,304,000 | +167.2% | 213,626 | -0.6% | 0.00% | – |
| Q1 2020 | $488,000 | -49.8% | 214,915 | +1.4% | 0.00% | -100.0% |
| Q4 2019 | $973,000 | +15.1% | 211,854 | -2.8% | 0.00% | – |
| Q3 2019 | $845,000 | -24.7% | 217,846 | +17.2% | 0.00% | -100.0% |
| Q2 2019 | $1,122,000 | -59.0% | 185,952 | -8.8% | 0.00% | -50.0% |
| Q1 2019 | $2,734,000 | +56.0% | 203,967 | +8.2% | 0.00% | +100.0% |
| Q4 2018 | $1,753,000 | -33.9% | 188,424 | -1.1% | 0.00% | -50.0% |
| Q3 2018 | $2,653,000 | -4.6% | 190,555 | +8.3% | 0.00% | 0.0% |
| Q2 2018 | $2,781,000 | +5.5% | 175,895 | +14.7% | 0.00% | 0.0% |
| Q1 2018 | $2,635,000 | -7.3% | 153,323 | +18.2% | 0.00% | 0.0% |
| Q4 2017 | $2,844,000 | -50.6% | 129,707 | -7.8% | 0.00% | -60.0% |
| Q3 2017 | $5,759,000 | +71.0% | 140,751 | +25.9% | 0.01% | +66.7% |
| Q2 2017 | $3,367,000 | -24.0% | 111,797 | -8.8% | 0.00% | -25.0% |
| Q1 2017 | $4,430,000 | -57.0% | 122,540 | -40.4% | 0.00% | -63.6% |
| Q4 2016 | $10,301,000 | -9.9% | 205,556 | -5.7% | 0.01% | -15.4% |
| Q3 2016 | $11,437,000 | +92.1% | 217,878 | +51.3% | 0.01% | +85.7% |
| Q2 2016 | $5,955,000 | +221.0% | 143,992 | +215.5% | 0.01% | +250.0% |
| Q1 2016 | $1,855,000 | +5.2% | 45,639 | +7.4% | 0.00% | 0.0% |
| Q4 2015 | $1,764,000 | +243.9% | 42,500 | +27.6% | 0.00% | +100.0% |
| Q3 2015 | $513,000 | -38.0% | 33,300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $828,000 | +8.8% | 33,300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $761,000 | +11.3% | 33,300 | +31.6% | 0.00% | 0.0% |
| Q4 2014 | $684,000 | +130.3% | 25,300 | 0.0% | 0.00% | – |
| Q3 2014 | $297,000 | -24.6% | 25,300 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $394,000 | – | 25,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,381,117 | $47,065,000 | 4.14% |
| GREAT POINT PARTNERS LLC | 1,647,753 | $22,937,000 | 3.58% |
| Rock Springs Capital Management LP | 598,000 | $8,324,000 | 0.30% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 136,029 | $1,894,000 | 0.14% |
| FOX RUN MANAGEMENT, L.L.C. | 20,935 | $291,000 | 0.13% |
| Hilltop Holdings Inc. | 39,824 | $554,000 | 0.12% |
| WEXFORD CAPITAL LP | 112,700 | $1,569,000 | 0.10% |
| OXFORD ASSET MANAGEMENT LLP | 296,339 | $4,132,000 | 0.09% |
| Vident Investment Advisory, LLC | 133,272 | $1,855,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 90,000 | $1,253,000 | 0.06% |